Search for: "GLAXOSMITHKLINE" Results 121 - 140 of 1,808
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Jun 2007, 3:36 pm
Issues surrounding GlaxoSmithKline's controversial diabetes drug Avandia continued today in a recent article published by ABCNEWS: Doctor to Testify in Avandia Hearing on Hill. [read post]
4 Aug 2015, 5:52 am by John Jascob
The SEC staff recently asked GlaxoSmithKline plc (GSK) to explain rapid changes in its overseas tax rates and intellectual property benefits as reported in its annual report on Form 20-F.U.K. tax rates. [read post]
27 Jul 2014, 9:38 pm by Patent Docs
GlaxoSmithKline LLC et al. v. [read post]
16 Sep 2009, 10:55 am
Though the researchers have denied being influenced by GlaxoSmithKline, plaintiffs will be able to probe the relationship and, perhaps, place it before a jury to decide. [read post]
9 Oct 2007, 9:16 pm
The agreement provides GlaxoSmithKline the option to select up to four targets for drug... [read post]
22 May 2009, 12:18 pm
Wall Street Journal: GlaxoSmithKline, IRS Tangle in Tax Court, by Jesse Drucker: GlaxoSmithKline PLC is embroiled in a potential $1.9 billion court battle with the Internal Revenue Service, which says the drug maker owes back taxes, interest and penalties stemming from tax deductions Glaxo generated essentially by making payments to... [read post]
6 Jul 2012, 3:22 pm by Christopher T. Hurley
In a deal with the US Department of Justice, drug manufacturer GlaxoSmithKline (GSK) recently agreed to plead guilty to criminal and civil charges for illegally promoting prescription drugs and failing to report critical safety data. [read post]
4 Nov 2011, 8:40 am by info@thomasjhenrylaw.com
Pharmaceutical giant GlaxoSmithKline will pay the U.S. government $3 billion to settle several investigations over questionable sales and marketing tactics. [read post]
12 Feb 2007, 9:37 pm
Watson Pharmaceuticals announced today that it has settled a patent infringement suit concerning GlaxoSmithKline's popular antidepressant Wellbutrin XL (bupropion HCl extended release tablets) for $35 million. [read post]
3 Jan 2011, 5:33 am by Joe Consumer
We were tickled pink last night to see 60 Minutes start the year off with the sensational story of Cheryl Eckard, the GlaxoSmithKline whistleblower whose courage and persistence led to one of the largest "qui tam" cases ever against a corporation for defrauding the government (See our earlier coverage here.) [read post]
3 Jan 2011, 5:33 am by Joe Consumer
We were tickled pink last night to see 60 Minutes start the year off with the sensational story of Cheryl Eckard, the GlaxoSmithKline whistleblower whose courage and persistence led to one of the largest "qui tam" cases ever against a corporation for defrauding the government (See our earlier coverage here.) [read post]
26 Oct 2010, 6:15 am by Ben Vernia
The Department of Justice announced on October 26 that GlaxoSmithKline has agreed to pay a total of $750 million, and have a subsidiary plead guilty to a felony violation of the Food, Drug and Cosmetic Act, settling allegations of adulterated drugs manufactured at a now-shuttered Puerto Rico plant. [read post]
6 Jul 2012, 1:50 pm by Steven Berk
John Buse was living a normal life as an endocrinologist before he blew the whistle on GlaxoSmithKline in 1999, thirteen years ago. [read post]
6 Nov 2011, 10:37 am by Ed Wallis
News Reports on GlaxoSmithKline Our team of Wellbutrin lawyers reviewed several recent articles about the decision of GlaxoSmithKline, which manufactuers Wellbutrin, to settle with the U.S. [read post]